VyGen-Bio
Industry
- Pharmaceuticals
- Biotechnology
- Gene Therapy, Cell Therapy
See more in Biomedtracker
Latest on VyGen-Bio
Scrip
• By Joseph Haas
Scrip regularly covers business development and deal making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Biomedtracker. Eyenovia, Betaliq Will Have Combined C
Scrip
• By Mandy Jackson
Blackstone has raised a new fund called Blackstone Life Sciences Yield (BXLS Yield), providing $1.6bn in additional capital for drug, device and diagnostic developers with late-stage assets. But while